top of page
Ablatotech clinicals

Join the Clinical Trial for Nygela Topical Cream

Are you living with psoriasis, eczema, or acne? Ablatotech, a leader in innovative biotherapeutics, is excited to announce a groundbreaking clinical trial for a natural, topical cream designed to redefine how we care for chronic skin conditions. This revolutionary solution aims to be a cost-effective, safer, and more effective alternative to immune-suppressing drugs currently on the market.

​

Our mission is simple: to harness the power of nature and cutting-edge science to deliver relief and improve the lives of those affected by these conditions. As a participant in this study, you will play a vital role in shaping the future of skincare treatments while receiving expert guidance and support throughout the trial.

​

Key Details:

  • This study is open to adults aged 18–65 with mild-to-moderate psoriasis, eczema, or acne.

  • Participants will apply the topical cream as directed over a 12-week period.

  • The trial includes regular check-ins with our team to ensure safety and monitor progress.

 

Why Join?

  • Be part of an innovative effort to transform skincare therapies.

  • Gain access to cutting-edge, natural treatments at no cost.

  • Help advance science and improve options for millions worldwide.

 

📅 Enrollment is now open, but spaces are limited! Be a part of this healthcare revolution today. Use the form below to sign up now!

Submitted! Thanks for your interest in Nygela clinical trials.

    © 2022 Ablatotech

    bottom of page